📝 Johnson Pharmacare Ltd — results explained
Quarter ended March 2026 (Q4 FY26)
Johnson Pharmacare Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).
The company reported a net loss of ₹56 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.01.
Full year and trailing twelve months
For the full year FY26, Johnson Pharmacare Ltd posted revenue of ₹0 crore, with a net loss of ₹56 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹56 crore.
Valuation snapshot
At the current price of ₹0.47, 532154 has a market capitalisation of ₹26 crore.
Within the Diversified Commercial Services industry, it is the 25th-largest of the 100 companies we track by market value.
Shareholding pattern
As of Mar 2026, public shareholders 99.99% of Johnson Pharmacare Ltd.